The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Can We Predict & Prevent Pregnancy Complications in Patients with Lupus & APS?

Can We Predict & Prevent Pregnancy Complications in Patients with Lupus & APS?

November 13, 2020 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR Convergence 2020ACR CONVERGENCE 2020—New evidence, though derived from small numbers, suggest that treatment with the TNF-inhibitor certolizumab could help improve high-risk pregnancy outcomes in women with antiphospholipid syndrome (with or without systemic lupus erythematosus) and lupus anticoagulants, an expert said.

You Might Also Like
  • Pregnancy Complications in Patients with Lupus & APS
  • Newer Targets Pave the Way for Future Lupus Therapies
  • Anti-TNF Treatment Trial Encouraging for High-Risk APS Pregnancies
Also By This Author
  • Lupus Nephritis: New Decade, New Approaches

In the Phase 2 IMPACT trial, which has already enrolled 27 women and is continuing to enroll patients, pregnancies with data that could be evaluated had much lower numbers of fetal demise or preeclampsia than what had been expected based on a review of prior literature.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Jane Salmon, MD, professor of medicine and professor of medicine in obstetrics and gynecology at the Hospital for Special Surgery, New York, discussed this new line of research in this Rheumatology Research Foundation Memorial Lectureship session to honor Shaun Ruddy, MD.

See our full coverage of this session and other ACR Convergence 2020 sessions.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: ACR Convergence, Conditions, Meeting Reports, SLE (Lupus), Systemic Inflammatory Syndromes Tagged With: ACR Convergence 2020, ACR Convergence 2020 - SLE

You Might Also Like:
  • Pregnancy Complications in Patients with Lupus & APS
  • Newer Targets Pave the Way for Future Lupus Therapies
  • Anti-TNF Treatment Trial Encouraging for High-Risk APS Pregnancies
  • Promote Pregnancy Wellness: Data Can Help Guide Pregnancy Management in Lupus

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.